• Dual-Action Weight Management Formula – Combines AOD-9604 synthetic peptide fragment with retatrutide triple receptor agonist for enhanced metabolic support
• Targets Multiple Pathways – Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously for comprehensive appetite and metabolism regulation
• Clinically-Backed Results – Phase 2 trial data shows significant weight loss outcomes, typically visible between weeks 8-12 of treatment
• Appetite Control & Metabolic Benefits – Reduces hunger, promotes fullness after smaller meals, and may improve blood glucose levels
• Subcutaneous Administration – Convenient self-injection into abdomen, front thigh, or outer upper arm following established GLP-1 injection protocols
AOD-9604 with Retatrutide: Advanced Weight Management Support
This combination therapy brings together two investigational compounds designed for obesity and metabolic management. AOD-9604 is a synthetic peptide fragment derived from human growth hormone, while retatrutide represents a breakthrough triple incretin receptor agonist currently advancing through Phase 3 clinical trials.
Retatrutide functions as a triple agonist, simultaneously targeting three critical metabolic receptors: GLP-1, GIP, and glucagon.
TIRZEPATIDE
RETATRUTIDE
SEMAGLUTIDE
CAGRILINTIDE
AOD9604
BPC-157
TB-500
GHK-CU
ELORALINTIDE
KLOW
KPV
CJC-1295
IPAMORELIN
TESAMORELIN
EPITHALON
NAD+
SELANK
PT-141
Send us a message if you have any questions or request a quote. Our experts will give you a reply within 24 hours and help you select the right valve you want.
All of our products are available for sampling
LCDP Fitness is your convenient and private online source for highest purity, quality certification, safety delivery peptides.
Ordering from us, your information with the highest remain encrypted standards protected and 100% discreet.
All of our products are available for ordering
